PharmaSens seeks FDA approval for new insulin pump

4.9 (76) · $ 19.99 · In stock

PharmaSens has submitted an application to obtain FDA approval for its ‘niia essential’ insulin patch pump system.

Abbott launches real-time remote neuromodulation tech - MassDevice

Animas® Vibe™ Insulin Pump and Continuous Glucose Monitoring

Most Read Archives - Page 5 of 309 - NS Medical Devices

First diabetes drug transparency report reveals profits, costs

FDA clears Tandem Mobi durable automated insulin pump

Metabolic Disorders Archives - Medical Device Network

PharmaSens seeks FDA approval for new insulin pump

Diabetotech

Wearable Tech Archives - Medical Device Network

FDA clears Beta Bionics' artificial pancreas system

FDA Approves Accu-Chek Solo Tubeless Patch Pump

You may also like